# Phase 4 disease trials recruiting: 151 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 151 trials in phase 4 for disease that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 4 disease trials: 151 rows for $7.55, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 4 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-4/disease

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 151
- Recruiting or not yet: 151
- Read on: November 19, 2026

## Trials

The 25 newest of 151, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 9, 2026 | NCT07925450 | Iron Treatment for Iron Deficiency Anemia in Children and Young Adults With Crohn's Disease | Weill Medical College of Cornell University | Phase 4 | Recruiting | Crohn's Disease, Iron Deficiency Anemia | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07925450) |
| November 3, 2026 | NCT07912801 | Roxadustat and Myocardial Injury After Off-Pump Coronary Artery Bypass Surgery | Peking University First Hospital | Phase 4 | Not yet recruiting | Coronary Artery Disease, Coronary Artery Bypass Grafting, Hypoxia-Inducible Factor 1, Alpha Subunit, Prolyl-Hydroxylase... | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07912801) |
| November 2, 2026 | NCT07910474 | FES PET/MRI for Occult Disease in Lobular Breast Cancer | University of Wisconsin, Madison | Phase 4 | Recruiting | Lobular Breast Carcinoma | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07910474) |
| October 22, 2026 | NCT07890857 | Superficial Parasternal Block Combined With Rectus Sheath Block for Open Cardiac Surgery | Hôpital du Valais | Phase 4 | Not yet recruiting | Cardiac Valve Disease, Coronary Heart Disease | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07890857) |
| October 13, 2026 | NCT07872449 | Risankizumab for Refractory Perianal Fistulizing Crohn's Disease | Sponsor not shown (see the record) | Phase 4 | Recruiting | Crohn Disease, Perianal Fistula, Perianal Fistula Due to Crohn's Disease, Perianal Crohn's Disease | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07872449) |
| September 24, 2026 | NCT07839793 | A 12-Week Study of Flexilev With the OraFID Device and App in Parkinson's Patients | Navamedic AB | Phase 4 | Recruiting | PARKINSON DISEASE (Disorder) | 58 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07839793) |
| September 24, 2026 | NCT07838155 | A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease | Eli Lilly and Company | Phase 4 | Not yet recruiting | Alzheimer Disease | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07838155) |
| September 8, 2026 | NCT07806019 | Metformin in Parkinson's Disease: Safety and Efficacy | Jinnah Medical & Dental College | Phase 4 | Not yet recruiting | Parkinsons Disease (PD) | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07806019) |
| September 4, 2026 | NCT07803679 | A Trial Assessing the Effectiveness of Evolocumab in Reducing the Plaque Burden in Participants With Subclinical Atheroma | Amgen | Phase 4 | Not yet recruiting | Coronary Artery Disease, Hypercholesterolemia, Atheroma, Atherosclerotic Plaque | 308 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07803679) |
| September 2, 2026 | NCT07799246 | Brain and Blood Vessel Health Following Endometriosis Treatment in People With Endometriosis | Colorado State University | Phase 4 | Not yet recruiting | Endometriosis, Endometriosis and Dysmenorrhea, Endometriosis (Diagnosis) | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07799246) |
| September 1, 2026 | NCT07796217 | Comparison of Clopidogrel-based Antiplatelet Agent Treatment and Aspirin Plus Low Dose Rivaroxaban Therapy | Seoul National University Bundang Hospital | Phase 4 | Recruiting | Cardiac Event, Coronary Artery Disease, Peripheral Artery Disease, Bleeding | 2,758 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07796217) |
| August 28, 2026 | NCT07793461 | Gastrointestinal Dopamine Decarboxylase and Levodopa Pharmacokinetics | Beth Israel Deaconess Medical Center | Phase 4 | Not yet recruiting | Parkinson's Disease | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07793461) |
| August 24, 2026 | NCT07782021 | MIRICURE: Mirikizumab With Curettage and Repair (Closure) for Perianal Fistulizing Crohn's Disease | Icahn School of Medicine at Mount Sinai | Phase 4 | Not yet recruiting | Crohn's Disease, Perianal Fistula | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07782021) |
| August 14, 2026 | NCT07766122 | Analysis of the Performance of PSMA Emission Tomography in Patients With Prostate Cancer Treated With HIFU | University Hospital, Toulouse | Phase 4 | Not yet recruiting | Prostate Cancer - Recurrent, Prostate Cancer (Diagnosis) | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07766122) |
| August 13, 2026 | NCT07762755 | Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CT | China National Center for Cardiovascular Diseases | Phase 4 | Not yet recruiting | Coronary Artery Disease, Hyperlipidaemia, Hypertriglyceridaemia, Coronary Atherosclerosis | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07762755) |
| August 12, 2026 | NCT07761351 | A Randomized Controlled Trial Comparing Percutaneous CT-Guided Biopsy and Shape-Sensing Robotic-Assisted Bronchoscopy | Intuitive Surgical | Phase 4 | Recruiting | Lung Cancer (Diagnosis), Lung Nodule | 550 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07761351) |
| July 31, 2026 | NCT07740330 | Oral Versus Intravenous Tranexamic Acid in Off-Pump Coronary Artery Bypass Surgery | Clinique Saint-Luc | Phase 4 | Not yet recruiting | Coronary Artery Disease, Perioperative Bleeding | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07740330) |
| July 15, 2026 | NCT07704190 | Effect of Secukinumab on Cardiorenal Outcomes in Patients With Cardiorenal Metabolic Syndrome and Atherosclerotic Cardiovascular Disease | Peking University Third Hospital | Phase 4 | Not yet recruiting | Cardiorenal Metabolic Syndrome, Atherosclerotic Cardiovascular Disease, Chronic Kidney Disease, Coronary Artery... | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07704190) |
| July 10, 2026 | NCT07695701 | Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis | Eidos Therapeutics, a BridgeBio company | Phase 4 | Recruiting | Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM), Amyloidosis, Amyloid Cardiomyopathy, Transthyretin Amyloidosis | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07695701) |
| July 8, 2026 | NCT07691138 | Stopping PPI Therapy in Inactive IBD | University of Nottingham | Phase 4 | Recruiting | Ulcerative Colitis (UC), Crohn's Disease | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07691138) |
| July 7, 2026 | NCT07688460 | Evaluation System for Lecanemab Efficacy Using Gold Electrode ECL to Monitor Alzheimer's Biomarkers | The Fourth Affiliated Hospital of Zhejiang University School of Medicine | Phase 4 | Recruiting | Alzheimer Disease | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07688460) |
| June 23, 2026 | NCT07663526 | Treatment of Chinese Adult Subjects With Moderate to Severe Crohn's Disease With Tabellvi® | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Phase 4 | Recruiting | Crohn's Disease | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07663526) |
| June 18, 2026 | NCT07657676 | Effect of Mazdutide on Coronary Plaque in Patients With Coronary Atherosclerosis and Overweight or Obesity | China National Center for Cardiovascular Diseases | Phase 4 | Recruiting | Obesity & Overweight, Coronary Heart Disease | 116 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07657676) |
| June 17, 2026 | NCT07654751 | A Remotely Conducted Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically | Janssen Research & Development, LLC | Phase 4 | Recruiting | Psoriasis, Colitis, Ulcerative, Crohn Disease, Arthritis, Psoriatic | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07654751) |
| June 16, 2026 | NCT07651891 | Evaluation of ALLERgen Specific Vaccination of DOG Allergic Patients in Swedish Practice | Karolinska Institutet | Phase 4 | Recruiting | Allergic Rhinitis, Asthma (Diagnosis) | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07651891) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| China National Center for Cardiovascular Diseases | 6 |
| University of Florida | 5 |
| Universitaire Ziekenhuizen KU Leuven | 3 |
| VA Office of Research and Development | 3 |
| Sixth Affiliated Hospital, Sun Yat-sen University | 3 |
| The First Affiliated Hospital with Nanjing Medical University | 3 |
| Emory University | 2 |
| Nanjing First Hospital, Nanjing Medical University | 2 |
| The Cleveland Clinic | 2 |
| Mayo Clinic | 2 |
| Asan Medical Center | 2 |
| Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2 |
| Chinese Medical Association | 2 |
| [Takeda](https://specstream.ai/data/clinical-trials/company/takeda) | 2 |
| First Affiliated Hospital of Wenzhou Medical University | 2 |
| Weill Medical College of Cornell University | 2 |
| The University of Texas Health Science Center at San Antonio | 2 |
| Centre Hospitalier Universitaire de Saint Etienne | 2 |
| Alimentiv Inc. | 2 |
| Fundación EPIC | 1 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 1 |
| Beth Israel Deaconess Medical Center | 1 |
| Colorado State University | 1 |
| Samsung Medical Center | 1 |
| Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 46 |
| China | 36 |
| South Korea | 10 |
| France | 10 |
| Belgium | 9 |
| Canada | 7 |
| Italy | 6 |
| United Kingdom | 5 |
| India | 4 |
| Sweden | 4 |
| Spain | 3 |
| Poland | 3 |
| Switzerland | 3 |
| Germany | 3 |
| Netherlands | 3 |
| Brazil | 2 |
| Finland | 2 |
| Denmark | 2 |
| Japan | 2 |
| Slovenia | 1 |
| Ireland | 1 |
| Kuwait | 1 |
| Mexico | 1 |
| Lebanon | 1 |
| Russia | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [TV service providers in the United States](https://specstream.ai/data/businesses/tv-service-providers/united-states)
- [Cleaning products suppliers in the United States](https://specstream.ai/data/businesses/cleaning-products-suppliers/united-states)
- [Importers in the United States](https://specstream.ai/data/businesses/importers/united-states)
- [Rail freight companies in the United States](https://specstream.ai/data/businesses/rail-freight-companies/united-states)
- [Australian restaurants in the United States](https://specstream.ai/data/businesses/australian-restaurants/united-states)
- [Endocrinology practices in the United States](https://specstream.ai/data/businesses/endocrinology-practices/united-states)
